SCMP - Sucampo Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue230,056153,180115,450
Cost of Revenue76,00336,73116,269
Gross Profit154,053116,44999,181
Operating Expenses
Research Development46,61533,63120,566
Selling General and Administrative46,27638,35945,753
Non Recurring7,2867,2865,631
Others---
Total Operating Expenses---
Operating Income or Loss53,87644,45927,231
Income from Continuing Operations
Total Other Income/Expenses Net-15,7406,0701,422
Earnings Before Interest and Taxes38,13650,52928,653
Interest Expense23,7616,8541,520
Income Before Tax14,37543,67527,133
Income Tax Expense-4,11210,30414,005
Minority Interest---
Net Income From Continuing Ops18,48733,37113,128
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income18,48733,37113,128
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares18,48733,37113,128